|
Duration between HIV test confirmed and enrollment
|
|
< 6 months
|
291
|
72.4
|
|
6–12 months
|
46
|
11.4
|
|
> 12 months
|
65
|
16.2
|
|
Any medication before ART initiation
|
|
No
|
299
|
74.4
|
|
Yes
|
103
|
25.6
|
|
Past OI at enrollment
|
|
No
|
214
|
53.2
|
|
Yes
|
188
|
46.8
|
|
Cotrimoxazole prophylaxis
|
|
No
|
42
|
10.4
|
|
Yes
|
360
|
89.6
|
|
INH prophylaxis
|
|
No
|
338
|
84.1
|
|
Yes
|
64
|
15.9
|
|
TB treatment history
|
|
No
|
336
|
83.6
|
|
Yes
|
66
|
16.4
|
|
Chronic disease
|
|
No
|
324
|
80.6
|
|
Yes
|
78
|
19.4
|
|
Immunization status
|
|
Appropriate for age
|
323
|
80.3
|
|
Not appropriate for age
|
67
|
16.7
|
|
Not Immunized
|
12
|
3
|
|
WHO stage at HIV test
|
|
I
|
136
|
33.8
|
|
II
|
133
|
33.1
|
|
III
|
98
|
24.4
|
|
IV
|
35
|
8.7
|
|
Functional status (≥ 5 years)
|
|
Working
|
120
|
47.8
|
|
Ambulatory/bedridden
|
131
|
52.2
|
|
Developmental milestone (< 5 years)
|
|
Appropriate ranges for age
|
116
|
76.8
|
|
Developmental delay/regression
|
35
|
23.2
|
|
CD4 count (> 5 years)
|
|
< 250 cells/mm3
|
50
|
20.2
|
|
≥ 250 cells/mm3
|
198
|
79.8
|
|
CD4 percentage (≤ 5 years)
|
|
< 15%
|
37
|
24.0
|
|
15–25%
|
39
|
25.3
|
|
> 25%
|
78
|
50.7
|
|
WHO stage at ART initiation
|
|
I
|
94
|
23.4
|
|
II
|
136
|
33.8
|
|
III
|
130
|
32.3
|
|
IV
|
42
|
10.5
|
|
Year of ART initiation
|
|
2007–2008
|
69
|
17.2
|
|
2009–2011
|
137
|
34.1
|
|
2012–2014
|
115
|
28.6
|
|
2015–2016
|
81
|
20.1
|
